The 340B Drug Discount Program is a US federal government program that enables covered entities to stretch scarce resources. Created in 1992, it requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices, enabling them to reach more patients and provide comprehensive services within underserved populations.
By using the 340B cost savings to implement rapid testing programs, you are widening the possible reach of your facility and cutting down the window of time between detection and linkage to care. OraQuick® HCV Rapid Antibody Test requires 3-easy steps and delivers results within 20 minutes. Rapid testing also provides peace of mind to the patient as they receive their results same day while face-to-face with their health care provider, and saves valuable time and resources for follow-up calls.
For more information visit www.OraSure.com/Request.
Does your organization also do HIV testing? Click Here.
©2015 OraSure Technologies, Inc. All Rights Reserved.